A. Dalmases

发表

F. Rojo, J. Albanell, A. Rovira, 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Inhibition of Specific NF-κB Activity Contributes to the Tumor Suppressor Function of 14-3-3σ in Breast Cancer

N. López-Bigas, Alba Jené-Sanz, R. Gomis, 2012, PloS one.

Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin

F. Rojo, J. Albanell, P. Gascón, 2007 .

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients

J. Albanell, B. Bellosillo, C. Montagut, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.

F. Rojo, J. Albanell, P. Gascón, 2007, Cell cycle.

Evolution of heterogeneous mechanisms of acquired resistance to cetuximab-based therapy in colorectal cancer.

S. Serrano, M. Salido, J. Albanell, 2014 .

Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer

F. Rojo, J. Albanell, L. Espinosa, 2013, Oncotarget.

Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer.

F. Rojo, J. Yélamos, J. Albanell, 2014, European journal of cancer.

HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer

J. Albanell, O. Arpí, S. Menéndez, 2019, Molecular Cancer Therapeutics.

Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations

M. Stratton, L. Stebbings, G. Bignell, 2017, bioRxiv.

Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR‐Mutant Lung Adenocarcinoma

M. Salido, J. Albanell, B. Bellosillo, 2018, Clinical lung cancer.

mTOR signaling in human cancer

F. Rojo, J. Albanell, A. Rovira, 2007 .

Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin

Beatriz Bellosillo, Ignasi Tusquets, Rosario Perona, 2009, Clinical Cancer Research.

Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer

M. Salido, A. Bardelli, J. Albanell, 2015, Clinical Cancer Research.

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

F. Bosch, S. Serrano, H. Himmelbauer, 2012, Nature Medicine.

Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients

S. Serrano, F. Rojo, J. Albanell, 2010, British Journal of Cancer.

Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy‐guided bronchoscopy

B. Bellosillo, R. Longarón, V. Curull, 2018, Cancer cytopathology.

Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report

M. Arumí-Uría, B. Bellosillo, C. Montagut, 2016, Journal of Medical Case Reports.

Predictors of Metachronous Risk Polyps After Index Colonoscopy

B. Bellosillo, Gemma Navarro, M. Andreu, 2021, Clinical and translational gastroenterology.

[The use of targeted therapies in oncology and their impact in the design of clinical trials: epidermal growth factor receptors 1 and 2 as a paradigm].

F. Rojo, J. Albanell, A. Rovira, 2013, Medicina clinica.

Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma.

M. Salido, B. Bellosillo, E. Carcereny, 2019, Lung cancer.

Accuracy of plasma RAS mutation testing for therapy selection and monitoring of colorectal cancer patients

J. Albanell, B. Bellosillo, C. Montagut, 2016 .

The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer

A. Bardelli, J. Albanell, J. Tabernero, 2016, Clinical Cancer Research.

Complementary value of electron microscopy and immunohistochemistry in the diagnosis of non-small cell lung cancer: A potential role for electron microscopy in the era of targeted therapy

M. Salido, B. Lloveras, L. Comerma, 2019, Ultrastructural pathology.